Investment Summary

Amadeus Capital Partners and Downing Exits Congenica

On September 2, 2025, SeqOne invested in software company Congenica from Amadeus Capital Partners and Downing

Investment Highlights
  • This is SeqOne’s 1st transaction in the Software sector.
  • This is SeqOne’s 1st transaction in the United Kingdom.

Investment Summary

Date 2025-09-02
Target Congenica
Sector Software
Investor(s) SeqOne
Sellers(s) Amadeus Capital Partners
Downing
Deal Type Add-on Acquisition

Target

Congenica

Cambridge, United Kingdom
Congenica is a digital health company offering a clinical decision support platform for accelerated genomic data interpretation. Congenica software enables genomic medicine by integrating genetic data into healthcare, empowering clinicians to provide life-changing answers that transform the lives of individuals, patients, and their families. Congenica was founded in 2012 and is based in Cambridge, England.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

SeqOne

Montpellier, France

Category Company
Founded 2017
Sector Life Science
DESCRIPTION

SeqOne is a deep-tech company committed to making personalized medicine a reality. Its AI-powered genomic analysis platform provides clinical decision-support tools that enable molecular laboratories to deliver fast, accurate, and scalable analysis of genetic data for applications in oncology, rare and inherited diseases, and infectious diseases. SeqOne was formed in 2017 and is headquartered in Montpellier, France.


DEAL STATS #
Overall 1 of 1
Sector: Software M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2025 M&A 1 of 1

Seller(S) 2

SELLER

Amadeus Capital Partners

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Amadeus Capital Partners is an early late-stage investor in high growth European technology companies. Specific areas of interest include AI & machine learning, online consumer services, cybersecurity, digital health and medical technology, digital media, enterprise SaaS, fintech, and insurtech. Amadeus Capital Partners was formed in 1997 and is based in London, United Kingdom.


DEAL STATS #
Overall 26 of 26
Sector: Software M&A 7 of 7
Type: Add-on Acquisition M&A Deals 20 of 20
Country: United Kingdom M&A 15 of 15
Year: 2025 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-09-02 Sphere Bio

Cambridge, United Kingdom

Sphere Bio is a life sciences tools company developing high-throughput single-cell analysis technologies using proprietary picodroplet microfluidics. Its Cyto-Mine® platforms accelerate biologics discovery, cell line development, and cell therapy research for global biopharma and biotech companies. Sphere Bio is based in Cambridge, United Kingdom.

Sell -
SELLER

Downing

Investor Investor Investor Investor Investor


Category Asset Manager
Founded 1986
PE ASSETS 1.9B GBP
Size Large
Type Sector Agnostic
DESCRIPTION

Downing is an alternative asset manager focused on a variety of investment strategies. These include renewable energy, infrastructure, property finance and development, and healthcare. Downing was founded in 1986 and is headquartered in London, United Kingdom.


DEAL STATS #
Overall 4 of 4
Sector: Software M&A 1 of 1
Type: Add-on Acquisition M&A Deals 3 of 3
Country: United Kingdom M&A 4 of 4
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-02 Ondat

London, United Kingdom

Ondat is a cloud-native, software-defined storage solution to deliver persistent storage for Kubernetes. Ondat is built from the ground-up with no legacy restrictions to give developers working with cloud-native workloads total control of storage with no compromise on performance, availability, or security. Ondat was founded in 2015 and is headquartered in London, United Kingdom.

Sell -